Exacerbation Copd
15
3
3
9
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
6.7%
1 terminated out of 15 trials
90.0%
+3.5% vs benchmark
13%
2 trials in Phase 3/4
0%
0 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (15)
Monitoring of the End-tidal Carbon Dioxide (EtCO2) as a Severity Criterion in COPD Exacerbations
REal-time Data Monitoring for Shared Adaptive, Multi-domain and Personalised Prediction and Decision Making for Long-term Pulmonary Care Ecosystems (RE-SAMPLE)
Respiratory Strategies in COPD Patients With Persistent Hypercapnia Following Exacerbation
High Flow Nasal Cannula Versus Non-Invasive Ventilation in Exacerbations of Chronic Obstructive Pulmonary Disease
AECOPD and Nutritional Supplementation in COPD
The COPD Attack Study
Exacerbations and Their Outcomes International (EXACOS International)
Effects of Inspiratory Muscle Training in Addition to Pulmonary Rehabilitation in Patients With COPD Exacerbation
POCT PCT in Outpatient LRTI
Determinants of Lower Limb Muscle Atrophy Induced During an Hospitalization for Exacerbation of COPD
Anti-viral Effects of Azithromycin in Patients With Asthma and COPD
15-year Mortality After Hospitalization for Exacerbation of Chronic Obstructive Pulmonary Disease
Respiratory Microbiome and COPD Exacerbations (RESMECOPD)
Efficacy of Roflumilast on Exacerbations in Patients With Non-cystic Fibrosis Bronchiectasis
A Sputum Screening Test to Rule-out Pneumonia at an Early Stage